Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Insulin Delivery Devices Market Introduction and Overview

According to SPER market research, 'Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Insulin Delivery Devices Market is predicted to reach USD 70.14 billion by 2033 with a CAGR of 8.71%.

The beta cells in the islets of Langerhans of the pancreas produce the hormone insulin. By promoting cellular glucose uptake and controlling the metabolism of fats, proteins, and carbohydrates, the hormone keeps blood glucose levels within normal ranges. Type I and type II diabetes can be brought on by inappropriate insulin function brought on by damaged beta cells or the body's incapacity to utilize the insulin that is produced.

Furthermore, the market for insulin delivery devices was significantly impacted by the COVID-19 pandemic. Patients with type 1 diabetes are more affected by COVID-19. Due to their already compromised immune systems, people with diabetes quickly deteriorate when exposed to COVID-19. Individuals with diabetes may be more susceptible than healthy individuals to major complications.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.

Insulin Delivery Devices Market Segmentation:

By Type: Based on the Method type, Insulin Delivery Devices Market is segmented as; Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standards & Safety).

By End User: Based on the End User, Insulin Delivery Devices Market is segmented as; (Hospitals & Clinics, Patients & Homecare).

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Product Code: HLCA2417

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Insulin Delivery Devices Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Insulin Delivery Devices Market

7. Insulin Delivery Devices Market, By Type (USD Million)

7.1. Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
7.2. Insulin Pens
7.3. Insulins Pumps
7.4. Insulin Syringes
7.5. Insulin Pen Needles

8. Insulin Delivery Devices Market, By End User (USD Million)

8.1. Insulin Delivery Devices Market Value Share and Forecast, By Vehicle type, 2023-2033
8.2. Hospitals & Clinics
8.3. Patients & Homecare

9. Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)

9.1. Insulin Delivery Devices Market Size and Market Share

10. Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)

10.1. Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)
10.2. Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)

11. Insulin Delivery Devices Market, By End User, 2019-2033 (USD Million)

11.1. Insulin Delivery Devices Market Size and Market Share By End User (2019-2026)
11.2. Insulin Delivery Devices Market Size and Market Share By End User (2027-2033)

12. Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)

12.1. Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
12.2. Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
12.3. Eastern Region
12.4. Western Region
12.5. Northern Region
12.6. Southern Region

13. Company Profile

13.1. Biocon Limited
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Diabetes Care Business
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. Eli Lilly and Company
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Hindustan Syringes & Medical Devices Ltd.
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Insulet Corporation
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Mannkind Corporation
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Sanofi
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. Terumo Corporation
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Vicentra B.V.
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Others